LC-SCRUM is a national registry that has enrolled over 19,000 lung cancer patients with broad mutation profiling, along with their clinical information. The registry has collaborated with 18 pharmaceutical companies in clinical trials of novel cancer therapies that led to multiple regulatory approvals. In addition, new companion diagnostics have been developed and marketed in Japan through the collaboration.
//Dr. Yoh and Dr Ikeda of the National Cancer Center Data Center, collaborator of PREMIA